rs137949961
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001369.3(DNAH5):c.8999G>A(p.Arg3000Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000207 in 1,613,260 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001369.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAH5 | NM_001369.3 | c.8999G>A | p.Arg3000Gln | missense_variant | 54/79 | ENST00000265104.5 | NP_001360.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAH5 | ENST00000265104.5 | c.8999G>A | p.Arg3000Gln | missense_variant | 54/79 | 1 | NM_001369.3 | ENSP00000265104 | P4 | |
DNAH5 | ENST00000681290.1 | c.8954G>A | p.Arg2985Gln | missense_variant | 54/79 | ENSP00000505288 | A1 |
Frequencies
GnomAD3 genomes AF: 0.000210 AC: 32AN: 152024Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000231 AC: 58AN: 250676Hom.: 0 AF XY: 0.000236 AC XY: 32AN XY: 135464
GnomAD4 exome AF: 0.000207 AC: 302AN: 1461118Hom.: 0 Cov.: 31 AF XY: 0.000216 AC XY: 157AN XY: 726840
GnomAD4 genome AF: 0.000210 AC: 32AN: 152142Hom.: 0 Cov.: 32 AF XY: 0.000202 AC XY: 15AN XY: 74378
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia Uncertain:2Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 27, 2019 | The p.R3000Q variant (also known as c.8999G>A), located in coding exon 54 of the DNAH5 gene, results from a G to A substitution at nucleotide position 8999. The arginine at codon 3000 is replaced by glutamine, an amino acid with highly similar properties. This variant was identified in a cohort of individuals of primary ciliary dyskinesia; however, additional genotype and phenotype information was limited (Andjelkovic M et al. PLoS ONE, 2018 Oct;13:e0205422). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on available evidence to date, the clinical significance of this alteration remains unclear. - |
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 09, 2024 | - - |
Primary ciliary dyskinesia 3 Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 14, 2021 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Counsyl | Dec 13, 2017 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Apr 24, 2019 | Identified by whole exome sequencing, along with a second DNAH5 variant, in an individual with a complex phenotype. However, this individual also harbors pathogenic variants in the BBS1 and SPAG1 genes.; Identified in an individual with primary ciliary dyskinesia, however, no second variant was identified (Andjelkovic et al., 2018); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 30293640, 30300419) - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at